首页|血液透析滤过联合血液透析治疗慢性肾衰竭的临床疗效及对肾功能的影响

血液透析滤过联合血液透析治疗慢性肾衰竭的临床疗效及对肾功能的影响

扫码查看
目的 探讨血液透析滤过联合血液透析治疗慢性肾衰竭的临床疗效及对肾功能的影响。方法 选择 2021 年 5月至 2023 年 2 月于新乡市第二人民医院血液中心治疗的 72 例慢性肾衰竭患者作为观察对象,以随机排列法的方式,将患者随机分为两组,每组各 36 例。分别接受血液透析治疗(单一组)和血液透析滤过+血液透析治疗(联合组),比较两组干预前后肾功能指标变化及炎症因子水平,比较两组不良反应发生情况。结果 治疗前,两组血清无机磷(P)、甲状旁腺激素(PTH)、血肌酐(Scr)、尿素氮(BUN)水平相比,差异均无统计学意义(P>0。05);治疗后,联合组P、PTH、Scr、BUN水平均低于单一组,差异具有统计学意义(P<0。05);两组治疗前血清降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、高敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6),差异无统计学意义(P>0。05),治疗后联合组IL-6、TNF-α、PCT、hs-CRP水平低于单一组,差异具有统计学意义(P<0。05);两组不良反应发生率相比,差异无统计学意义(P>0。05)。结论 血液透析滤过联合血液透析治疗慢性肾衰竭患者疗效显著,能够使患者的肾功能指标得到改善,其作用机制可能与体内各型分子毒素清除彻底、炎性反应减轻有关,值得临床使用。
Clinical Efficacy of Hemodialysis Filtration Combined with Hemodialysis in the Treatment of Chronic Renal Failure and Its Impact on Renal Function
Objective To explore the clinical efficacy of hemodialysis filtration combined with hemodialysis in the treatment of chronic renal failure and its impact on renal function.Methods 72 patients with chronic renal failure treated in the Blood Center of The Second People's Hospital of Xinxiang from May 2021 to February 2023 were selected as the observation objects.They were randomly divided into two groups,each with 36 cases,by the method of random arrangement.They were treated with hemodialysis(single group)and hemodialysis filtration+hemodialysis(combined group),respectively.The changes of renal function indicators and the level of inflammatory factors before and after intervention in the two groups were compared,and the occurrence of adverse reactions in the two groups was compared.Results Before treatment,there was no significant difference in inorganic phosphorus(P),parathyroid hormone(PTH),serum creatinine(Scr),and blood urea nitrogen(BUN)levels between the two groups(P>0.05);after treatment,the levels of P,PTH,Scr,and BUN in the combined group were lower than those in the single group,and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in serum procalcitonin(PCT),tumor necrosis factor-α(TNF-α),high-sensitivity C-reactive protein(hs-CRP),and interleukin-6(IL-6)between the two groups(P>0.05);after treatment,the levels of IL-6,TNF-α,PCT,and hs-CRP in the combined group were lower than those in the single group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The treatment of chronic renal failure patients with hemodialysis filtration combined with hemodialysis has significant efficacy,can improve the renal function indicators of patients,and its mechanism of action may be related to the thorough clearance of various molecular toxins in the body and the alleviation of inflammatory response,which is worth clinical application.

hemodialysis filtrationhemodialysischronic renal failurerenal function

孙园园

展开 >

新乡市第二人民医院 肾病风湿免疫科,河南 新乡 453000

血液透析滤过 血液透析 慢性肾衰竭 肾功能

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(8)